Search results
NATIONALLY RANKED ROSEN LAW FIRM Encourages Akero Therapeutics, Inc. Investors to Secure Counsel...
Benzinga· 4 hours agoNEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ:AKRO) between September 13, 2022 and October
DiaMedica Therapeutics (NASDAQ:DMAC) Shares Up 1.1%
ETF DAILY NEWS· 2 days agoDiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report)’s share price shot up 1.1% on Friday . The stock traded as high as $2.90 and last traded at $2.88. 9,783 shares ...
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoWith a gene therapy for two illnesses out the door, and with sales slated to take off over the next few quarters, CRISPR Therapeutics (NASDAQ: CRSP) is...
News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT)...
Simply Wall St. via Yahoo Finance· 5 days agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the...
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Down 3.1% Following Weak Earnings
ETF DAILY NEWS· 3 days agoCalliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report)’s stock price dropped 3.1% during trading on Friday after the company announced weaker than expected quarterly ...
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Down to $16.19
ETF DAILY NEWS· 5 days agoNurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) gapped down before the market opened on Tuesday . Nurix Therapeutics shares last traded at $15.86 ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) to Post Q2 2024 Earnings of ($0.35) Per Share, HC...
ETF DAILY NEWS· 7 days agoAllogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – HC Wainwright raised their Q2 2024 earnings estimates for shares of Allogene Therapeutics in a ...
This Neumora Therapeutics Insider Increased Their Holding In The Last Year
Simply Wall St. via Yahoo Finance· 5 days agoInsiders were net buyers of Neumora Therapeutics, Inc.'s (NASDAQ:NMRA ) stock during the past year....
Galectin Therapeutics (NASDAQ:GALT) Stock Price Passes Above Two Hundred Day Moving Average of $2.25
ETF DAILY NEWS· 7 days agoGalectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving ...
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $84.00
ETF DAILY NEWS· 3 days agoCRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price objective dropped by investment analysts at Citigroup from $89.00 to $84.00 in a research note issued on ...
